CHPA Elects Board and Officers at Annual Executive Conference

Aventura, Florida (March 15, 2003)–Directors and officers of the Consumer Healthcare Products
Association (CHPA) were elected today during the Association’s March 13-15 Annual Executive Conference. Richard K. Green, president and chief operating officer, Blistex Inc., was reelected CHPA chairman. Timothy G. Hayes, senior vice president & region head, North America, Consumer Care Division, Bayer HealthCare LLC, was named chairman-elect. Charles J. Hinkaty, president, Del Pharmaceuticals, Inc., was reelected immediate past chairman.

Elected to CHPA’s Board of Directors for the first time were:

  • Mary Lynn Ferguson-McHugh, vice president, Global Personal Health Care, The Procter & Gamble Company;
  • Marjorie L. Fine, senior vice president, general counsel, Shaklee Corporation;
  • Gordon Knapp, president, Consumer Healthcare North America, Pfizer Inc;
  • Peter C. Mann, president & chief executive officer, Medtech Holdings, Inc.;
  • Gregory C. Pulido, chairman & chief executive officer, Humco Holding Group, Inc.; and
  • Matthew I. Seiden, chief executive officer, president, The Seiden Group.

Reelected to the CHPA Board of Directors were:

  • Jeffrey S. Himmel, chairman & chief executive officer, Himmel Pharmaceuticals Inc.;
  • Daniel R. Johnson, senior vice president, general counsel, secretary and board member, Combe Incorporated;
  • Steven R. LaMonte, senior vice president-marketing, Schering-Plough HealthCare Products, Inc.; and
  • Lynne Millheiser, senior vice president, OTC Business Unit North America, Novartis Consumer Health, Inc.

Returning to the CHPA Board of Directors were:

  • Gale K. Bensussen, president, Leiner Health Products Inc., and
  • Gary R. Downing, chief executive officer, Lansinoh Laboratories, Inc.

Elected as vice chairmen to the CHPA Executive Committee for the first time were:

  • William L. McComb, president, McNeil Consumer & Specialty Pharmaceuticals, and
  • Douglas A. Rogers, president, U.S. Healthcare Division, Wyeth Consumer Healthcare.

Reelected as vice chairmen to the CHPA Executive Committee were:

  • Patrick M. Lonergan, partner, president, NUMARK Laboratories;
  • Mark P. Olesnavage, executive vice president, Perrigo Company; and
  • Manfred E. Scheske, president, North America, GlaxoSmithKline Consumer Healthcare.

Reelected as honorary vice chairman was:

  • John W. Culligan, director emeritus, Wyeth.

Contacts: Virginia Cox and Donna Edenhart, 202.429.9260


CHPA is the 122-year-old trade association representing U.S. manufacturers and distributors of overthe-counter medicines and nutritional supplement products.